System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof Alexandre Ouattara is an expert in Anesthesiology at Centre Hospitalier Universitaire de Bordeaux (France). As of October 2026, ScienceLeadR ranks Alexandre Ouattara in the top 1% of experts worldwide for Epidemiologic Studies. Alexandre Ouattara has authored 295 publications, the most recent in 2026, and is an investigator in 33 clinical trials, 6 of them ongoing. SLR score: 1,362 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Alexandre Ouattara Centre Hospitalier Universitaire de Bordeaux France
1 362 ScienceLeadR Reputation 1362

Unlock

Register Login
Network Map

Anesthesiology

Subspecialties: Critical Care - Cardiology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2002 - 2026
Source: PubMed

University of Bordeaux

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 295

Citations

Citations: 10 014 1st author: 22 Last author: 83 Unique author: 2

Main journals

Anaesth Crit Care Pain Med 28
Anesthesiology 20
Intensive Care Med 19
Anesth Reanim 14
J Cardiothorac Vasc Anesth 14

Best Journals

JAMA 5
Intensive Care Med 4
Am J Respir Crit Care Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Lunar phases, meteorological conditions, astrological signs, and postoperative outcomes of acute type A aortic dissection: Results of a retrospective cohort study.
PMID 42908132 — mortality, incidence, emergencies, cohort studies, cardiopulmonary bypass, signs and symptoms, morbidity, heart disease risk factors, aortic dissection, dissection		Perfusion20260
Push the flow-mind the micro: renal microcirculation during high-flow cardiopulmonary bypass.
PMID 42182730 — microcirculation, kidney, cardiopulmonary bypass		J Thorac Dis20260
Fulminant recurrent myocarditis complicated by papillary muscle rupture and cardiogenic shock managed with ExtraCorporeal membrane oxygenation and impella support.
PMID 42031392 — mitral valve, muscles, shock, cardiogenic, extracorporeal membrane oxygenation, myocarditis, papillary muscles, therapeutics, rupture, membranes		BMJ Case Rep20260
Dapagliflozin for cardiorenal protection after intensive care unit discharge: a protocol for a randomised controlled trial evaluating dapagliflozin at ICU discharge for cardiorenal protection (DAPA-ICU).
PMID 41991273 — mortality, teaching, heart failure, heart, biomarkers, intensive care units		BMJ Open20260
Experts' recommendations for the management of adult patients with cardiogenic shock.
PMID 41994317 — shock, cardiogenic		Ann Intensive Care20261

Clinical Studies 33

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 6

By phase:

N/A 22
Phase 3 10
Phase 2 1

By status:

Completed 23
Recruiting 5
Terminated 3
Not yet recruiting 1
Unknown 1

By type:

Interventional 26
Observational 7

By Monocentric/Multicentric:

monocentric 14
multicentric2to4 2
multicentric5to9 7
multicentricup10 10

Main Topics

Cohort/Consortium Investigators 6

Ongoing Clinical Trials

6 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Dapagliflozine for cardio renal protection at ICU discharge
2024-510941-32-00 — intensive care units		Phase 3Recruiting2025
Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery
NCT07278661 — injections, platelet count, growth, blood, therapeutics, blood platelets, thrombocytopenia, patient blood management		Phase 2Recruiting2026
Dapagliflozin for Cardio renal Protection After ICU Discharge
NCT07025629 — kidney diseases, sodium-glucose transporter 2 inhibitors, heart failure, heart, recycling, tablets, kidney, biomarkers, critical illness, intensive care units, random allocation, cardio-renal syndrome		Phase 3Recruiting2025
COmbined pLaTelet and eRythrocyte AutotransfusioN During Cardiac surgEry (COLTRANE) Trial
NCT06425614 — arterial pressure, cells, blood transfusion, anesthesia, remifentanil, blood transfusion, autologous, hemorrhage, erythrocytes, blood, point-of-care systems, tranexamic acid, central venous catheters, antifibrinolytic agents, propofol, cardiopulmonary bypass, length of stay, sufentanil, blood cells, postoperative period, therapeutics, blood platelets, infusions, intravenous, point-of-care testing, pulse, catheters, electrocardiography		N/ARecruiting2024
Impact of Non invasive Individualized Goal directed Fluid Therapy on Outcomes Following Thoracic Cancer Surgery
NCT06156943 — thoracic neoplasms, neoplasms, cardiac output, anesthesiologists, therapeutics, fluid therapy		N/ANot yet recruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS